Effectiveness of pneumococcal polysaccharide vaccine against pneumonia and cost analysis for the elderly who receive seasonal influenza vaccine in Japan
- 8 October 2010
- Vol. 28 (43) , 7063-7069
- https://doi.org/10.1016/j.vaccine.2010.08.010
Abstract
No abstract availableKeywords
This publication has 34 references indexed in Scilit:
- Burden of disease caused by Streptococcus pneumoniae in children younger than 5 years: global estimatesThe Lancet, 2009
- Incidence of Pneumococcal Bacteremia Requiring Hospitalization in Rural ThailandClinical Infectious Diseases, 2009
- Vaccines: Pneumococcal Vaccination of Elderly Adults: New Paradigms for ProtectionClinical Infectious Diseases, 2008
- Impact of the introduction of pneumococcal conjugate vaccine on rates of community acquired pneumonia in children and adultsVaccine, 2008
- Drug‐resistant genes and serotypes of pneumococcal strains of community‐acquired pneumonia among adults in JapanRespirology, 2006
- Prior Pneumococcal Vaccination Is Associated with Reduced Death, Complications, and Length of Stay among Hospitalized Adults with Community-Acquired PneumoniaClinical Infectious Diseases, 2006
- The Burden of Community‐Acquired Pneumonia in Seniors: Results of a Population‐Based StudyClinical Infectious Diseases, 2004
- 23–valent pneumococcal polysaccharide vaccine in HIV-1-infected Ugandan adults: double-blind, randomised and placebo controlled trialThe Lancet, 2000
- Community-acquired pneumoniaThe Lancet, 1998
- The Protective Efficacy of Polyvalent Pneumococcal Polysaccharide VaccineNew England Journal of Medicine, 1991